Does medical technology generated in frontier countries have a significant impact on health outcomes in the rest of the world? This paper considers a framework where non-frontier countries may benefit from medical innovation that is embodied in medical imports or diffuses in the form of ideas....

The importance of trade costs in segmenting product markets cannot be captured by considering aggregate prices or in the absence of information on the direction of trade. We address this problem by utilizing product-specific prices along with cross-sectional productivity measures and bilateral...

Does medical technology originating in countries close to the technology frontier have a significant impact on health outcomes in countries distant from this frontier? This paper considers a framework where lagging countries may benefit from medical technology (a result of research and...